Cargando…
Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease
Ewing's sarcoma tumors are associated with chromosomal translocation between the EWS gene and the ETS transcription factor gene. These unique target sequences provide opportunity for RNA interference(i)-based therapy. A summary of RNAi mechanism and therapeutically designed products including s...
Autores principales: | Simmons, Olivia, Maples, Phillip B., Senzer, Neil, Nemunaitis, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317005/ https://www.ncbi.nlm.nih.gov/pubmed/22523703 http://dx.doi.org/10.5402/2012/247657 |
Ejemplares similares
-
Pilot Trial of FANG Immunotherapy in Ewing's Sarcoma
por: Ghisoli, Maurizio, et al.
Publicado: (2015) -
Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's Sarcoma
por: Rao, Donald D., et al.
Publicado: (2016) -
Preclinical Assessment of wt GNE Gene Plasmid for Management of Hereditary Inclusion Body Myopathy 2 (HIBM2)
por: Jay, Chris, et al.
Publicado: (2008) -
Letter to the editor: Does Dicer Expression Affect shRNA processing?
por: Senzer, Neil, et al.
Publicado: (2009) -
Emerging technologies for the genomic analysis of cancer
por: Nemunaitis, John, et al.
Publicado: (2009)